These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
256 related articles for article (PubMed ID: 19356516)
21. Echocardiographic assessment of patients with hypertrophic and restrictive cardiomyopathy: imaging and echocardiography. Tam JW; Shaikh N; Sutherland E Curr Opin Cardiol; 2002 Sep; 17(5):470-7. PubMed ID: 12357122 [TBL] [Abstract][Full Text] [Related]
22. Evolving anatomic, functional, and molecular imaging in the early detection and prognosis of hypertrophic cardiomyopathy. Fuster V; van der Zee S; Miller MA J Cardiovasc Transl Res; 2009 Dec; 2(4):398-406. PubMed ID: 20559998 [TBL] [Abstract][Full Text] [Related]
23. [Hopeful future for echocardiography. Progress within both the function and perfusion areas]. Brodin LA; Janerot-Sjöberg B Lakartidningen; 2000 Nov; 97(46):5302-4, 5307-9. PubMed ID: 11116868 [TBL] [Abstract][Full Text] [Related]
24. Fibrosis suggested by 3D contrast-enhanced echocardiography in hypertrophic cardiomyopathy. Labombarda F; Pellissier A; Saloux É Arch Cardiovasc Dis; 2011 Dec; 104(12):680-1. PubMed ID: 22152519 [No Abstract] [Full Text] [Related]
25. [Echocardiography findings in hypertrophic cardiomyopathies. Diagnostic value of different echocardiography procedures]. Kneissl GD; Kaltenbach M Fortschr Med; 1992 Oct; 110(29):536-40. PubMed ID: 1427550 [TBL] [Abstract][Full Text] [Related]
26. Differentiation of hypertrophic cardiomyopathy and cardiac amyloidosis from other causes of ventricular wall thickening by two-dimensional strain imaging echocardiography. Sun JP; Stewart WJ; Yang XS; Donnell RO; Leon AR; Felner JM; Thomas JD; Merlino JD Am J Cardiol; 2009 Feb; 103(3):411-5. PubMed ID: 19166699 [TBL] [Abstract][Full Text] [Related]
27. Can transthoracic live 3-dimensional echocardiography improve the recognition of midventricular obliteration in hypertrophic obstructive cardiomyopathy? de Gregorio C; Recupero A; Grimaldi P; Coglitore S J Am Soc Echocardiogr; 2006 Sep; 19(9):1190.e1-4. PubMed ID: 16950476 [TBL] [Abstract][Full Text] [Related]
34. Clinical and echocardiographic aspects of mid-ventricular hypertrophic cardiomyopathy. Martínez Baca-López F; Lilia Rayas-Gómez A; Ramírez-Arias E; Marisol Alonso Bravo R; Yáñez-Gutiérrez L; Bernal-Ruiz E; Silva-Oropeza E Echocardiography; 2005 Jul; 22(6):517-24. PubMed ID: 15966938 [TBL] [Abstract][Full Text] [Related]
35. Tissue Doppler imaging assessment of long axis left ventricular function in hypertrophic cardiomyopathy. Cardim N; Castela S; Cordeiro R; Longo S; Ferreira T; Pereira A; Gouveia A; Reis RP; Correia JM Rev Port Cardiol; 2002 Sep; 21(9):953-85. PubMed ID: 12416269 [TBL] [Abstract][Full Text] [Related]
36. Regional diastolic function in hypertrophic cardiomyopathy: a tissue Doppler echocardiographic study. Cardim N; Longo S; Pereira T; Ferreira T; Pereira A; Ramos A; Rodrigues M; Correia M Rev Port Cardiol; 1997; 16(7-8):615-9, 588. PubMed ID: 9290308 [TBL] [Abstract][Full Text] [Related]
37. Abnormal longitudinal myocardial functional reserve assessed by exercise Doppler tissue echocardiography in patients with hypertrophic cardiomyopathy. Song ZZ; Ma J J Am Soc Echocardiogr; 2007 Jun; 20(6):785. PubMed ID: 17543759 [No Abstract] [Full Text] [Related]
38. Differentiation of hypertrophic cardiomyopathy from other forms of left ventricular hypertrophy by means of three-dimensional echocardiography. Caselli S; Pelliccia A; Maron M; Santini D; Puccio D; Marcantonio A; Pandian NG; De Castro S Am J Cardiol; 2008 Sep; 102(5):616-20. PubMed ID: 18721523 [TBL] [Abstract][Full Text] [Related]